Moderate drinking can be good for your heart. But for women, drinking alcohol raises the risks of breast cancer.
Hindu priest Pandjitee is not overweight, does not smoke or drink and follows a strict vegetarian diet. Yet three years ago he was suddenly struck by a heart attack.
What the heck are triglycerides? If you don't know, you have plenty of company.
"A couple hours after surgery, he was entertaining the medical team," says his surgeon
Ordinarily, walking on a treadmill is no big deal for Carol Elam -- except when she's dressed in a hospital gown and attached to a heart monitor.
Ask third-graders what cholesterol means and they will probably just shrug their shoulders, but not Maddie Zacks.
What should we include in our diet to increase HDL and lower LDL and triglycerides?
The comic, in the midst of a concert tour, was experiencing shortness of breath
Is CoQ10 beneficial for people taking statins?
What is the name of the new diet to lower cholesterol that Dr. Sanjay Gupta talked about on "House Call" on CNN?
Moderate drinking can be good for your heart. But for women, drinking alcohol raises the risks of breast cancer.
Hindu priest Pandjitee is not overweight, does not smoke or drink and follows a strict vegetarian diet. Yet three years ago he was suddenly struck by a heart attack.
What the heck are triglycerides? If you don't know, you have plenty of company.
"A couple hours after surgery, he was entertaining the medical team," says his surgeon
Ordinarily, walking on a treadmill is no big deal for Carol Elam -- except when she's dressed in a hospital gown and attached to a heart monitor.
Ask third-graders what cholesterol means and they will probably just shrug their shoulders, but not Maddie Zacks.
What should we include in our diet to increase HDL and lower LDL and triglycerides?
The comic, in the midst of a concert tour, was experiencing shortness of breath
Is CoQ10 beneficial for people taking statins?
What is the name of the new diet to lower cholesterol that Dr. Sanjay Gupta talked about on "House Call" on CNN?
Five days after giving birth to her daughter, Rhonda Monroe laid Dominique back in her crib after nursing, sat down and had a heart attack.
Are cardiac tests such as the stress echo as effective at diagnosing blockages and arrhythmia in women as they are in men?
The musician reveals his son has atypical Kawasaki Disease – and was released from the hospital
Cholesterol-lowering drugs called statins are often hailed as "wonder drugs." But a study published in the January 2008 issue of the journal Neurology says they don't protect the brain against Alzheimer's disease.
Women who have used the bone-building drug Fosamax are nearly twice as likely to develop the most common kind of chronically irregular heartbeat as those who have never used it. Patients, especially those with family history of heart problems, should talk to their doctor about whether the drug is the appropriate option for them. The study was published in the Archives of Internal Medicine in April 2008.
December 26 could be one of the most dangerous days of the year for people vulnerable to cardiac problems, including heart attacks, arrhythmias, and heart failure. And many of these so-called Merry Christmas coronaries will hit people who didn't even realize they were at risk when they unwrapped their gifts the night before.
Want to avoid a heart attack or stroke? In addition to well-known risk factors like diet and exercise, you may want to keep an eye on your vitamin D levels too.
An expensive CT scan that uses multiple X-rays to produce spectacular 3-D images of the heart can't replace tried-and-true coronary angiography for finding blocked blood vessels in chest-pain patients, according to a study in the New England Journal of Medicine.
French scientists have unveiled a working prototype of a fully artificial heart which is based on the technology of satellites and airplanes.
In the race to build a better artificial heart, French scientists have turned to technology from satellites and airplanes to create a heart that they say responds better to the human body
Cholesterol has long been seen as the key culprit in cardiovascular disease. But nearly half of all heart attacks occur in people with normal cholesterol levels, which suggests that another factor is at work.
About one in two American adults has borderline or high cholesterol levels, which increase one's risk of heart attack and cardiovascular disease.
Fish oil supplements may work slightly better than a popular cholesterol-reducing drug to help patients with chronic heart failure
Makiri Pugh is not your typical college freshman. At age 18, he knows more than most young adults about the structure and health of his heart, and it's not because he's sick.
When I had my heart attack at 43, all my doctors were really surprised. I was young, I'm not overweight, and I don't eat a lot of fatty foods.
Scientists may have found a way to test for and possibly avoid the most serious side effect of cholesterol-lowering statin drugs, one of the top-selling medicines in the world
Our circadian rhythm plays a crucial but little-known role in heart attack risk. The most dangerous time of day for your heart may surprise you
From curbside snack carts to four-star restaurants, New York City chefs have until next summer to rid their kitchens of trans fat. It's a bold move, but a necessary one, according to city health officials.
Your genes don't ordain heart disease. Researchers are learning more about the lifestyle factors that predict heart health, and these are in your hands.
Drugmaker Merck & Co. will start cutting checks for former users of its withdrawn painkiller Vioxx next month
Should cholesterol drugs be given to children? New guidelines have caused a stir among doctors and parents
A 52-year-old Milwaukee-area man has been accused of faking heart attacks to avoid paying restaurant bills
Most patients see a cardiologist for the first time after a referral from an internist or general practitioner.
Tim Russert's personal physician says medics tried to save the NBC anchor shortly after he collapsed at work.
Despite passing a stress test on April 29, the newsman's personal doctor says he died of a heart attack
Merck & Co. has halted a study of an experimental drug it had touted as key to energizing its sagging cholesterol franchise, barely three weeks after U.S. regulators refused to allow sales of the drug
Blood cholesterol is a risk factor for coronary artery disease and heart attack, so reducing your risk of high cholesterol is a worthy goal.
A government researcher said Monday that experimental blood substitutes are linked to an increased risk of heart attack and death, and suggested that studies on people should be halted.
Children should be screened for heart problems with an electrocardiogram before getting drugs like Ritalin to treat hyperactivity and attention-deficit disorder, the American Heart Association recommends
Merck said Monday its first-quarter earnings jumped due to income from a partnership, but the drugmaker's sales showed just a slight gain.
A large study offers the strongest evidence yet that a diet the government recommends for lowering blood pressure can save people from heart attack and stroke
Schering-Plough's stock jumped Thursday, after the drugmaker's chief executive announced he would cut 10% of its staff.
Joshua Miller trotted off the football field after making a special-teams play and headed to the bench.
Creating a replacement heart for some of the sickest patients may be one step closer, if new research in rats pans out in humans.
Whether it's a partner's snore or an airplane's roar, noises can affect you even if they fail to rouse you from sleep. A new study tries to figure out why
Schering-Plough may have lost billions of dollars in the fourth quarter from an acquisition, but its stock jumped Tuesday as the drugmaker's earnings without charges beat expectations.
As Schering-Plough unveils full-year financial results for 2007 tomorrow, CEO Fred Hassan is likely to be peppered with questions about how he managed a recently released study of embattled cholesterol drug, Vytorin.
Lets face it: All the information around cholesterol makes it something of a confusing topic. Not only do we make our own cholesterol, but we also must have it to produce other important body assets, such as cell membranes and certain types of hormones.
Is low cholesterol the pathway to a healthier heart? That's certainly what most medical experts - and their patients - have assumed for the last 30 years or so. But a recently-released study of Merck and Schering-Plough's cholesterol-lowering drug, Vytorin, is giving new voice to medical critics who have groused for decades about the questionable benefit of using medications to lower cholesterol and thereby prevent heart disease.
Merck & Co. reported a surge in fourth-quarter operating earnings Wednesday that exceeded analysts' estimates, but shares slumped in early trading.
More big drugmakers are on tap this week to report strong 2007 earnings, but that's because 2006 was an easy act to follow.
Government regulators said Friday they are analyzing recent study results regarding cholesterol drug Vytorin, but that it's too early to tell whether it will take any regulatory action.
How's your cholesterol? Here's a guess: If you're healthy, you probably have no idea. New surveys show women tend to be clueless about their risks of heart disease, especially when it comes to managing their cholesterol.
Schering-Plough's stock almost crawled out of its hole Wednesday after a two-day lashing sparked by the results of a cholesterol drug trial, but the shares fell just before the market's close.
Surprising study results show that the popular heart drug doesn't live up to its claims -- and three new trials are now under way
Anger, depression and stress can all raise the risk of heart disease -- but a new study shows that chronic anxiety may be even more harmful
The drugmakers Merck and Lilly are the biggest players in Big Pharma's late-stage pipeline, with three possible new blockbusters expected in the coming months.
Jeopardy host Alex Trebek was hospitalized Tuesday after suffering a minor heart attack.
The drugmaker Merck & Co. said Tuesday that it will seek federal approval for two new experimental drugs next year, adding that it's on track to meet its sales targets.
It's been a long time since 66-year-old Judy Borgula has seen the inside of a classroom, but a near-death experience forced her back to school -- "Heart School."
Merck & Co. announced Friday that it will pay $4.85 billion to settle as claims by as many as 47,000 groups of plaintiffs over injuries linked to its blockbuster Vioxx painkiller.
The cause of implantable heart defibrillators took a hit Tuesday when researchers reported the results of two studies that failed to reach their objectives.
A researcher unveiled on Monday the results of a failed Pfizer Inc. study showing that an experimental but dangerous cholesterol drug offers medical benefits too significant to be ignored.
Eli Lilly revealed positive findings from a late-stage trial of its experimental heart drug prasugrel, but a side effect might prevent it from becoming the potential blockbuster that the company had hoped.
Abbott Laboratories unveiled significant test results Sunday for an experimental cholesterol treatment that could go on sale as soon as next year.
Diabetes is the fifth-leading killer of Americans, according to the American Diabetes Association. A sobering two out of three people with type I or type II diabetes will die from a heart attack or stroke -- the combined leading causes of death among diabetics.
New research shows the adage "what doesn't kill us makes us stronger" doesn't apply in treating breast cancer.
Cholesterol-lowering statins may help stave off lung deterioration in the elderly, and even in patients with emphysema and COPD
Studies show that chronic stress contributes to heart attacks and other disease, and researchers think it's time to make stress reduction a medical priority
Drugmaker Schering-Plough is a favorite of analysts and investors these days. It's no wonder: The company's flagship product, the cholesterol-fighting Vytorin, is breaking sales records and faces relatively little risk from cheaper generic versions from rivals.
David Beckham flew back to the U.K. Thursday after his father, Ted Beckham, suffered a heart attack.
Actos and Avandia have entered the spotlight again, as studies published in a leading medical journal pit the two diabetes drugs against each other by comparing their cardiovascular risks.
Patients who switched from the cholesterol-cutting drug Lipitor to the competitor simvastatin increased their risk of suffering heart attacks and strokes, according to a study that Pfizer unveiled on Wednesday.
Patients who switched from the cholesterol-cutting drug Lipitor to the competitor simvastatin increased their risk of suffering heart attacks and strokes, according to a study that Pfizer unveiled on Wednesday.
A new study suggests that popular cholesterol-lowering drugs like Lipitor may help not just the heart, but the brain as well
Deer hunting could be a dangerous endeavor for men with heart disease or risk factors for it, research findings suggest.
Pfizer lost the latest round in a patent battle over the declining blockbuster Lipitor that could be worth $6 billion to the pharma giant.
U.S. regulators said Thursday they are reviewing new safety data on AstraZeneca Plc's heartburn drugs Nexium and Prilosec, but a preliminary analysis does not suggest they increase the risk of heart problems.
Food and Drug Administration panelists voted Monday that GlaxoSmithKline's diabetes drug Avandia should remain on the market, despite an analysis showing links to increased risk of heart attack.
GlaxoSmithKline Plc's widely used diabetes drug Avandia should be pulled off the market, Food and Drug Administration reviewer David Graham said in a presentation prepared for delivery Monday.
People who drank more than one diet soda each day developed the same risks for heart disease as those who downed sugary regular soda
Creating custom food plans for patients isn't the hard part of Bethany Thayer's job. For the Michigan-based registered dietitian and spokesperson for the American Dietetic Association, one of the most difficult aspects of her work is helping patients interpret the often-contradictory health news they hear each day.
Schering-Plough Corp. said Monday that second-quarter earnings rose sharply, fueled by growing demand for its Zetia and Vytorin cholesterol drugs and treatments for arthritis and allergies.
GlaxoSmithKline is getting ready for a face-to-face with the FDA about its diabetes drug Avandia, which has been on the hot seat since a study blamed the drug for increasing the risk of heart attack.
Pfizer Inc. on Wednesday reported lower-than-expected quarterly earnings on competition with generics, and said global sales of cholesterol fighter Lipitor fell 13 percent amid slipping demand for the company's flagship product.
Pfizer is not in the best of shape. The beating its stock took on Wednesday shows it. The question is, should the drug maker diet or bulk up?
While being fat increases your chances of a heart attack, some studies suggest a puzzling paradox: Obese people seem have a better chance of surviving one
Debate over the heart attack risk associated with the GlaxoSmithKline diabetes drug Avandia took center stage Monday at the annual meeting of the American Diabetes Association.
Cholesterol-lowering statins - which include the world's top-selling drug, Lipitor - and other drugs called fibrates can lower the risk of developing a common form of nerve damage in diabetics that often results in amputations, according to study results unveiled Friday.
With concerns raised about heart risks of a popular diabetes drug, GlaxoSmithKline and the FDA scramble to respond
The recently published study results that link GlaxoSmithKline's blockbuster diabetes drug Avandia to heart attacks could shift market share to rivals Merck, Lilly and Amylin, despite questions surrounding the data, analysts say.
It's hard out there for drug sales reps--particularly if they work in places where gaining access to doctors is becoming increasingly difficult.
Novartis pulled its irritable bowel syndrome drug Zelnorm off the U.S. market at the FDA's request because of a possible stroke risk to patients, the company said Friday.
An extremely potent experimental cholesterol drug being developed by Eli Lilly and Co. failed to show an advantage over an existing treatment sold by Abbott Laboratories Inc. in a clinical trial that could determine the fate of the medicine.
As Big Pharma faces patent expirations on some of its most lucrative drugs, the industry is trying to reinvigorate sales by finding creative ways to land new patents - but on the same old drugs.
An experimental drug from AtheroGenics and its partner AstraZeneca failed a late-stage clinical trial and is not considered an effective treatment in reducing heart disease, the companies said.
There's nothing unusual about a Big Pharma company with outgoing blockbusters and a weak pipeline. Virtually every major drugmaker in America is struggling with this issue.
The American Heart Association estimates nearly 5 million Americans are living with heart failure. More than half-a-million new cases are diagnosed each year. One of the most common forms is called congestive heart failure. CNN medical correspondent Judy Fortin learned more about it from cardiologist Dr. Wendy Book of Emory School of Medicine.
Heart problems? Me?
When Jean Horgan complained of heart palpitations, her doctor told her it was just nerves.
| Most Viewed | Most Emailed | Top Searches |
© 2009 Cable News Network. Turner Broadcasting System, Inc. All Rights Reserved.
